Frontiers in Oncology (Sep 2022)

Safety evaluation of early drain removal following pancreaticoduodenectomy: A single-center retrospective cohort study

  • Xuehai Xie,
  • Kai Chen,
  • Zonghao Liu,
  • Feng Wang,
  • Yongsu Ma,
  • Shupeng Zhang,
  • Zhijiang Shao,
  • Yinmo Yang,
  • Xiaodong Tian

DOI
https://doi.org/10.3389/fonc.2022.993901
Journal volume & issue
Vol. 12

Abstract

Read online

ObjectivesThe effects of early drain removal (EDR) on postoperative complications after pancreaticoduodenectomy (PD) remains to be investigated. This single-center retrospective cohort study was designed to explore the safety of EDR after PD.MethodsA total of 112 patients undergoing PD with drain fluid amylase (DFA) on postoperative day (POD) 1 and 3 <= 5000 were divided into EDR and late drain removal (LDR). Propensity Score Matching (PSM) was used. We compared postoperative outcomes between two groups and explore the risk factors of total complications using univariate and multiple logistic regression analyses.ResultsNo statistical differences were found in primary outcomes, including Grade B/C postoperative pancreatic fistula (POPF) (Original cohort: 5.71% vs. 3.90%; P = 1.000; PSM cohort: 3.33% vs. 6.67%; P = 1.000), and total complications (Original cohort: 17.14% vs. 32.47%; P = 0.093; PSM cohort: 13.33% vs. 33.33%; P = 0.067). The EDR was associated with shorter in-hospital stay (Original cohort: 11 days vs. 15 days; P < 0.0001; PSM cohort: 11 days vs. 15 days; P < 0.0001).ConclusionsEDR on POD 3 is safe for patients undergoing PD with low risk of POPF.

Keywords